News
Biophytis Is Deploying Its Partnership Strategy In Obesity
29 Apr 24
News
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
25 Apr 24
Why Teradyne Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
25 Apr 24
News, Pre-Market Outlook, Markets, Movers
Biophytis Plans To File IND With FDA For Phase 2 OBA Clinical Study In Obesity, Backed By New Scientific Advisory Board
18 Apr 24
News
Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
15 Apr 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Press releases
Biophytis grants Blanver Exclusive Rights to BIO101 in Latin America in Deal Valued at up to €108 Million
20 Jun 24
Biotech, News, Press Releases
Biophytis Extends Its Contract With Atlas to Secure Financing for Its Business Activities
19 Jun 24
News, Press Releases
Biophytis Announces the Successful Industrial Transfer of BIO101 (20-hydroxyecdysone) Production by its Service Provider Seqens
12 Jun 24
News, Press Releases
Biophytis Announces Filing of an IND Application with the US FDA for its Phase 2 Study in Obesity
10 Jun 24
News, Press Releases
Combined General Meeting of June 24, 2024
7 Jun 24
News, Press Releases
Biophytis Announces the Design of its Phase 2 OBA Clinical Study in Obesity
14 May 24
News, Press Releases
Biophytis is Deploying its Partnership Strategy in Obesity
29 Apr 24
Biotech, News, Press Releases
Biophytis Announces New Scientific Advisory Board for its Phase 2 OBA Clinical Study in Obesity
18 Apr 24
News, Press Releases